![](/img/cover-not-exists.png)
Ipilimumab alone or in combination with radiotherapy in metastatic castration-resistant prostate cancer: results from an open-label, multicenter phase I/II study
Slovin, S. F., Higano, C. S., Hamid, O., Tejwani, S., Harzstark, A., Alumkal, J. J., Scher, H. I., Chin, K., Gagnier, P., McHenry, M. B., Beer, T. M.Volume:
24
Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdt107
Date:
July, 2013
File:
PDF, 177 KB
english, 2013